Tech Company Financing Transactions
ImmunONE Funding Round
ImmunONE closed a $2.4 million funding round on 10/25/2023. Backers included MEIF Proof of Concept & Early Stage Fund, Mercia's EIS Funds and Pioneer Group.
Transaction Overview
Company Name
Announced On
10/25/2023
Transaction Type
Venture Equity
Amount
$2,426,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to move into new headquarters in Milton Keynes, new laboratories in Stevenage to meet the growing demand and additionally expand capacity, continue its research and development, grow its team and create six new jobs.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
Undisclosed
Hatfield, AL10 9AB
UK
Hatfield, AL10 9AB
UK
Phone
Undisclosed
Website
Email Address
Overview
ImmuONE is a biotech company established in April 2019 and is home to experienced scientists. Dr Victoria Hutter and Dr Abigail Martin started ImmuONE because they are strong believers in the need for relevant alveolar models that better represent human physiology. Abigail commercially validated her developed model during her Ph.D. which led to further support and funding by InnovateUK.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bigail Martin
Chief Scientific Officer
Victoria Hutter
Browse more venture capital transactions:
Prev: 10/25/2023: Sidework venture capital transaction
Next: 10/25/2023: Neon Machine venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs